(PZ) 뉴스

Unfortunately, I have so far very few shares of $FORW but I think you are right and I will definitely collect a few more shares of $FORW today before it rises above 0.01 and never goes back below that
imho

Trogocytosis can impact both CAR-T, as well as CAR-NK therapies. Strategies to overcome trogocytosis-induced antigen loss, fratricide and/or cell exhaustion include, pharmacological targeting, modulating CAR affinity, 'armouring,' modulating the signalling domain(s), or using a dual CAR strategy. So

Unfortunately, I have so far very few shares of $FORW but I think you are right and I will definitely collect a few more shares of $FORW today before it rises above 0.01 and never goes back below that
imho

He's not going to reply to your questions.  He can't, because he doesn't talk to JK, he has no facts, and I'd dare to if he half the shares he says that he has. I'm calling BS!!!
He brings nothing to the table with any substance, because he hasn't done zero DD. 
He's probably a pd trol

Do you have some FACTS to support your allegation?
Or are you just unhappy that this board is not talking about $NBRI which you have been promoting in the messages you have been repeatedly posting?
Or are you a market-maker with a short position?
If you have some FACTS, pleas

$GVSI looks huge and I don't want to imagine where $GVSI will be in the summer...... maybe $GVSI will be the stock of the year this year after all. We'll see
imho

$GVSI looks huge and I don't want to imagine where $GVSI will be in the summer...... maybe $GVSI will be the stock of the year this year after all. We'll see
imho

Awesome Product Line ---->
https://investorshub.advfn.com/uimage/uploads/2025/1/14/fpdfnALL_PRODUCT_SHEET_18_UPD_JAN_25_REDUCED.png

GO SRMX(TCCI)$

Charts: SPX 60 min--Slow Stoch Turning Down----Macd looks like headed below 0 line ? Almost to top of L/Term Falling Channel Upper T/L ?? Caution if not holding the Friday Pivots !

And what has he said, that YOU believe?
I ... have read the reports and talked with the CEO multiple times! What reports have you read? What SANE point would you like to make about them?

What has the CEO told you during these "multiple" conversations?

Do you th

Doc Logic,

Do you know about the following trial run by UPENN? 60% patients had OS over three years, which strikes me as pretty good results. George Coukos who was the PI for the trial on ovarian cancer with NWBO as one of the collaborators was listed as one of coauthors in the public

flipper44,

Nope, we don’t disagree. NWBO has one chance to make this right after all this time. Their worth as management to long time shareholders comes down to how well they are prepared to respond publicly with the MAA decision. The bears have greased the skids for disappointmen

Did somebody say Quectel and Qualcomm ❓❓❓
Nice E-Bike
https://investorshub.advfn.com/uimage/uploads/2025/1/12/pqrnyTIME_1303_A.png
https://investorshub.advfn.com/uimage/uploads/2025/1/17/uywsduwolz1736817403232.jpg

GO SRMX(TCCI)$

Another good find ge. Keep em coming. That's about the best promotion of critical minerals I have seen to date. Hopefully the Trump Admin can finally once and for all, help get NioCorp financed. Fingers xssed.

Be careful. It's obviously in limbo right now

You didn't attempt to answer ONE question!
THE BIGGER QUESTION IS blah blah blah There ARE NO BIGGER QUESTIONS HERE!!

If you DO in fact own 110MM shares, and if you HAVE in fact "talked with the CEO multiple times", then help everyone out:

Take a shot:
G

I Smell Another ---->
https://investorshub.advfn.com/uimage/uploads/2020/8/28/volouSRMX_VICTORY_MONEY.jpg

GO SRMX(TCCI)$

The class action should be against you and your lies and hype for 20 years.

Does anyone know why this doubled in the last few days. I've been away.

tim ord
https://www.youtube.com/watch?v=leKNC2Jz6IU

I looked at the transcript and at the 6:50 mark this was said, ringcon we were really at The Cutting.

So I asked copilot if Burba, ever worked there here is my coversation with copilot:


(Me) ringcon we were really at The Cutting
It sounds like you're refe

CRMD- I might be wrong on $12 target

that I gave yesterday. Here is why. Yesterday I assumed the PE going forward for biotech with a new drug ramping up strongly was around 20. However I could be wrong after doing some more digging. It seems some companies ie HZNP after Tepezza, s